Henderson Jeffrey William

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Henderson Jeffrey William's trades of Halozyme Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-28 2025-04-28
PlS Planned sale
76,455 +16.0%
393.23
US$2,649,355 		76,455 +16.0% 393.23 US$2,649,355
2025-04-28 2025-04-28
PlS Planned sale
21,303 -7.8%
212.31
US$2,569,661 		21,303 -7.8% 212.31 US$2,569,661
2025-04-01 2025-04-01
PlS Planned sale
5,199 +49.0%
317.41
US$4,981,743 		5,199 +49.0% 317.41 US$4,981,743
2025-03-03 2025-03-03
PlS Planned sale
3,205 -8.7%
59.12
US$189,467 		3,205 -8.7% 59.12 US$189,467
2025-03-03 2025-03-03
PlS Planned sale
1,795 -4.6%
57.93
US$103,992 		1,795 -4.6% 57.93 US$103,992
2025-02-10 2025-02-10
B Purchase
1,500 +23.0%
233.62
US$350,430 		1,500 +23.0% 233.62 US$350,430
2025-02-04 2025-02-03
PlS Planned sale
3,900 -9.2%
56.41
US$219,980 		3,900 -9.2% 56.41 US$219,980
2025-02-04 2025-02-03
PlS Planned sale
1,100 -2.5%
55.94
US$61,537 		1,100 -2.5% 55.94 US$61,537
2025-02-03 2025-02-03
PrS Proposed sale
15,000
56.64
US$849,600 		15,000 56.64 US$849,600
2025-01-07 2025-01-06
PlS Planned sale
10,000 -18.7%
50.01
US$500,060 		10,000 -18.7% 50.01 US$500,060
2025-01-06 2025-01-06
PrS Proposed sale
10,000
47.74
US$477,400 		10,000 47.74 US$477,400
2023-09-06 2023-09-01
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -6.5%
1.03
US$2,060 		2,000 -6.5% 1.03 US$2,060
2023-09-01 2023-09-01
US FibroGen Inc (FGEN)
PrS Proposed sale
2,000
1.06
US$2,120 		2,000 1.06 US$2,120
2023-08-08 2023-08-04
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -6.1%
1.91
US$3,820 		2,000 -6.1% 1.91 US$3,820
2023-08-04 2023-08-04
US FibroGen Inc (FGEN)
PrS Proposed sale
2,000
1.91
US$3,820 		2,000 1.91 US$3,820
2023-07-13 2023-07-11
US FibroGen Inc (FGEN)
PlS Planned sale
2,000 -5.7%
2.69
US$5,380 		2,000 -5.7% 2.69 US$5,380
2023-07-11 2023-07-11
US FibroGen Inc (FGEN)
PrS Proposed sale
2,000
2.73
US$5,460 		2,000 2.73 US$5,460
2023-06-09 2023-06-08
US FibroGen Inc (FGEN)
PlS Planned sale
4,994 -12.5%
17.69
US$88,344 		4,994 -12.5% 17.69 US$88,344
2023-06-09 2023-06-08
US FibroGen Inc (FGEN)
PlS Planned sale
2,006 -4.8%
16.87
US$33,841 		2,006 -4.8% 16.87 US$33,841
2023-06-08 2023-06-08
US FibroGen Inc (FGEN)
PrS Proposed sale
7,000
17.78
US$124,460 		7,000 17.78 US$124,460
2023-03-01 2023-03-01
S Sale
10,000 -20.4%
47.71
US$477,100 		10,000 -20.4% 47.71 US$477,100
2023-03-01 2023-02-28
S Sale
10,000 -16.9%
48.51
US$485,100 		10,000 -16.9% 48.51 US$485,100
2023-02-24 2023-02-23
US Qualcomm Inc (QCOM)
S Sale
2,500 -54.3%
124.19
US$310,468 		2,500 -54.3% 124.19 US$310,468
2023-02-24 2023-02-22
US Qualcomm Inc (QCOM)
S Sale
2,500 -35.2%
124.05
US$310,132 		2,500 -35.2% 124.05 US$310,132
2020-11-25 2020-11-25
S Sale
24,498 -34.0%
40.08
US$981,757 		24,498 -34.0% 40.08 US$981,757
2020-11-12 2020-11-10
US Qualcomm Inc (QCOM)
S Sale
6,000 -83.2%
141.10
US$846,602 		6,000 -83.2% 141.10 US$846,602